ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ITS CORRELATION WITH SERUM TESTOSTERONE LEVELS
Article Sidebar
Main Article Content
Abstract
Objective:
To determine erectile dysfunction in patients with Type 2 Diabetes Mellitus (DM-II) and its correlation with serum testosterone levels.
Methodology:
Patients with type 2 diabetes participated in this prospective cross-sectional study at Department of Medicine, Khyber Teaching Hospital Peshawar from October 2022 to April 2023. After approval from institutional ethical review board, strict inclusion/exclusion criteria were followed to minimize the confounders. The sample size was calculated by OpenEpi.com, keeping the prevalence of erectile dysfunction in Pakistani diabetics at 97.8% with 5% as the error margin and a 95% confidence level. The data were recorded on well-designed questionnaire and Lynn criteria validated these items having a threshold of 0.80 by six subject experts. An SPSS version 22.0 was used to analyze various variables statistically and a p-value of 0.05 or lower was regarded as significant.
Results:
Amongst one hundred and fifty type- 2 diabetic male patients, 87 (58%) of the study population had ED. Fifty-three (35.3 %) had hypertension (HTN), 18 (12%) had dyslipidemia, and 63 (42%) had diabetic complications as co-existent co-morbidities. There were more patients with Low testosterone and ED 58.6% (n=51) than those with normal testosterone and ED 43.1% (n=36). Among T2DM patients with ED (n=87), 75.8% had poor glycemic control (HbA1c >8%) and among hypertensive patients (n=53), 81.1% had ED.
Conclusion:
Erectile dysfunction is common in poorly controlled diabetics and diabetes of long duration. In our study, there is no substantial relationship between testosterone levels and ED.
Article Details
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Yusuf MM, Omar JM. Knowledge, attitude, and practice regarding lifestyle modification among type 2 diabetes patients with cardiovascular disease at a Tertiary Hospital in Somalia. Ann Med Surg. 2022;79:103883. DOI: 10.1016/j.amsu.2022.103883.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional, and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022; 183: 109119. DOI: 10.1016/j.diabres.2021.109119
Irfan M, Hussain NH, Noor NM, MoYusuf MM, Omar JM. Knowledge, attitude, and practice regarding lifestyle modification among type 2 diabetes patients with cardiovascular disease at a Tertiary Hospital in Somalia. Ann Med Surg. 2022;79:103883. DOI: 10.1016/j.amsu.2022.103883
Irfan M, Hussain NH, Noor NM, Mohamed M, Sidi H, Ismail SB. Epidemiology of male sexual dysfunction in Asian and European regions: a systematic review. Am J Mens Health. 2020;14(4). DOI: 10.1177/1557988320937200
Klein R, Klein BE, Lee KE, Moss SE, Cruickshank’s KJ. Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care. 1996; 19:135–1.
Fallahi M, Mozaffari-Khosravi H, Afkhami-Ardekani M, Dehghani A. Evaluation of sexual function in men with diabetes mellitus type 2 at Yazd Diabetes Research Center. Iran J Diabetes Obes. 2014; 6(3): 136-41.
Hurt KJ, Musicki B, Palese MA, Crone JK, Becker RE, Moriarity JL, et al. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci. 2002; 99(6): 4061-6.
Mikhailichenko VV, Tiktinskii OL, Silnitskii PA, Vorokhobina NV, Aleksandrov VP. The pathogenesis of sexual disorders in men with diabetes mellitus. Urologiia Inefrologiia. 1993(2): 47-50.
Penson DF, Latini DM, Lubeck DP, Wallace KL, Henning JM, Lue TF. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care. 2003; 26(4):1093-9.
Rance J, Phillips C, Davies S, O'Malley B, Zaman Q, Price D. How much of a priority is treating erectile dysfunction? A study of patients’ perceptions. Diabet Med. 2003; 20(3): 205-9.
Ahmed I, Aamir Au, Anwar E, Ali SS, Ali A, Ali A. Erectile dysfunction and type 2 diabetes mellitus in northern Pakistan. J Pak Med Assoc. 2013;63(12): 1486-90.
Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med. 2009; 6(5):1232-47. DOI: 10.1111/j.1743-6109.2008.01168.x.
Schaivi RC, Stimmel BB, Mandeli J, Ray Field EJ. Diabetes mellitus and male sexual function in a controlled study. Diabetologia. 1993; 36: 749–51. DOI: 10.1007/BF00401146
Kloner RA. Assessment of cardiovascular risk in patients with erectile dysfunction: Focus on the diabetic patients. Endrocrine. 2004; 23:125 - 9.
Sasaki H, Yamasaki H, Ogawa K, Nanjo K, Kawamori R, Iwamoto Y, et al. Prevalence and risk factors for erectile dys-function in Japanese diabetics. Diabetes Res Clin Pract. 2005; 70: 81–9.
Ledda A. Diabetes hypertension and erectile dysfunction. Curr Med Res Opin. 2000; 16: S17–20.
Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A, et al. Hypertension is associated with severe erectile dysfunction. J Urol. 2000; 164(4): 1188-91.
Heikkila A, Kaipia A, Venermo M, Kautiainen H, Korhonen P. Relationship of blood pressure and erectile dysfunction in men without previously diagnosed hypertension. J Sex Med.2017;14(11):1336-41. DOI: 10.1016/j.jsxm.2017.09.007
Jensen J, Lendorf A, Stimpel H, Frost J, Ibsen H, Rosenkilde P. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J of Hypertension. 1999; 12(3): 271–5.
Doumas M, Tsakiris A, Douma S. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J Androl. 2006; 27(3): 469-77.
Ishikawa K, Sasaki H, Tanifuji S. Lipid abnormality, current diabetes and age affect erectile hardness: an analysis of data from complete medical check ups carried out at a single hospital. Int J Urol. 2020; 27(4): 339-43. DOI: 10.1111/iju.14200
Omar SM, Musa IR, Idrees MB. Prevalence and associated factors of erectile dysfunction in men with type 2 diabetes mellitus in eastern Sudan. BMC Endocr Disord. 2022; 22(1):1-8 DOI: 10.1186/s12902-022-01060-0.
Stanworth RD, Kapoor D, Channe KS, Jones TH. Dyslipidemia is associated with testosterone, oestradiol, and androgen receptor CAG repeat polymorphism in men with type 2 diabetes. Clin Endocrinol. 2011;74(5): 624-30. DOI: 10.1111/j.1365-2265.2011.03969.x.
Azhar S, Khan F, Khan S. Raised Glycated Hemoglobin (HbA1c) Level as a Risk Factor for Myocardial Infarction in Diabetic Patients: A Hospital-Based, Cross-Sectional Study in Peshawar. Cureus. 2022; 14(6): e25723. DOI:10.7759/cureus.25723.
Widyaningsih N, Ahsani DN. Correlation of Age, Duration of Diabetes Mellitus, HbA1c Level and Erectile Dysfunctions in Type 2 Diabetes Mellitus. Proceedings of the 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing
(ICoSIHSN 2020). 2021. DOI: 10.2991/ahsr.k.210115.031.
Jumani J, Deepak K, Patil O. Erectile Dysfunction in Diabetes Mellitus. J Diabetology. 2020,11: 1-7. DOI: 10.4103/job.jod -42-18.
Defeudis G, Mazzilli R, Tenuta M. Erectile dysfunction and diabetes: A melting pot of circumstances and treatments. Diabetes Metab Res Rev. 2022; 38(2):e3494. DOI: 10.1002/dmrr.3494.